Výsledky vyhledávání - "Joycelyn Sim"

Akademický článek

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain

Autor: Hoi Ki Karen Tang, Chi Yeung Fung, Gareth J. Morgan, Shaji Kumar, Lisa Siu, Ho Wan Alvin Ip, Sze Fai Yip, Ka Ngai Harry Lau, Chi Kuen Lau, Harold Lee, Kwan Hung Leung, Bonnie Kho, Howard Wong, Cheong Ngai, Yu Yan Hwang, Joycelyn Sim, Yok Lam Kwong, Chor Sang Chim

Publikováno v: Therapeutic Advances in Hematology, Vol 13 (2022)

Introduction: Bortezomib has been reported to favourably impact the outcomes of t (4;14) and del(17p) in multiple myeloma (MM), but its impact on gain 1q (+1q) is unknown. Methods: To address this, 250 patients treated with bortezomib-based induction

Externí odkaz: https://doaj.org/article/9e151dd4f498461cadbd594b9833c864

Zobrazit plný text záznamu

Transfusion of pathogen‐reduced platelet components without leukoreduction

Autor: Wai Chiu Tsoi, Laurence Corash, Albert K. W. Lie, Claudia Koontz, Amy Yingjie Liu, Hans Vermeij, Cheuk-Kwong Lee, Rock Leung, Adonis Stassinopoulos, Joycelyn Sim, Norman Huang, Richard J. Benjamin, Clarence C.K. Lam

Publikováno v: Transfusion

Background Leukoreduction (LR) of platelet concentrate (PC) has evolved as the standard to mitigate risks of alloimmunization, clinical refractoriness, acute transfusion reactions (ATRs), and cytomegalovirus infection, but does not prevent transfusio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d2bf68ffd5ea9ccc7200ecb119ebd9c
http://europepmc.org/articles/PMC6850058

Zobrazit plný text záznamu

Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome

Autor: Bin-Miao Liang, Anskar Y.H. Leung, David C.L. Lam, Joycelyn Sim, Albert K. W. Lie, Terence C.C. Tam, Eric Tse, Mary S.M. Ip, Yok L. Kwong, Macy Mei Sze Lui, Wang‐Chun Kwok

Publikováno v: Respirology. 24:459-466

Background and objective Bronchiolitis obliterans syndrome (BOS) after haematopoietic stem cell transplantation (HSCT) presents with lung function decline. The pattern of lung function decline after BOS diagnosis could impact prognostication of BOS a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::13d73c0e1d4d73893dc1c733058cf0e0
https://doi.org/10.1111/resp.13472

Zobrazit plný text záznamu

P-181: Treatment outcome and prognostic factors of newly diagnosed Multiple Myeloma receiving Bortezomib-based induction in Hong Kong: an analysis of 448 patients

Autor: Chi Kuen Lau, Bonnie Kho, Eric Tse, Yok-Lam Kwong, Chor Sang Chim, Yu-Yan Hwang, Elaine Au, Hoi Ki Karen Tang, Joycelyn Sim, Kwan Hung Leung, Sze Fai Yip, Harold K. K. Lee, Chi Yeung Fung, Howard Wong

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S136-S137

Background Autologous stem cell transplant (ASCT) is the standard of care for eligible patients with newly diagnosed multiple myeloma (NDMM). In Hong Kong, NDMM received bortezomib-based triplet induction. NDMM ≤65 years of age were considered tran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e5a116018358e53071917a0af56e339e
https://doi.org/10.1016/s2152-2650(21)02308-9

Zobrazit plný text záznamu

P-062: The impact of Bortezomib-based induction on chromosome 1q21 gained newly diagnosed Multiple Myeloma of Chinese origin

Autor: Chi Kuen Lau, Lisa Siu, Ho Wan Alvin Ip, Yok-Lam Kwong, Kwan Hung Leung, Joycelyn Sim, Hoi Ki Karen Tang, Howard Wong, Gareth J. Morgan, Ka Ngai Harry Lau, Yu-Yan Hwang, Sze Fai Yip, Chor Sang Chim, Harold K. K. Lee, Chi Yeung Fung, Bonnie Kho, Cheong Ngai

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S72-S73

Background Bortezomib has been reported to favourably impact the outcome of high risk MM predominantly t(4;14) and in some report 17p- its impact on gain 1q21 is unknown. Methods To address this deficit, we have analysed CD138-sorted bone marrow plas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b23b977013c62c3e75c87ddf64721521
https://doi.org/10.1016/s2152-2650(21)02196-0

Zobrazit plný text záznamu

Treatment and unmet needs in steroid-refractory acute graft-versus-host disease

Autor: Xiao-Jun Huang, Florent Malard, Joycelyn Sim

Publikováno v: Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, ⟨10.1038/s41375-020-0804-2⟩
Leukemia, 2020, ⟨10.1038/s41375-020-0804-2⟩

Acute graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (alloHCT) and is a major cause of morbidity and mortality. Systemic steroid therapy is the first-line treatment for aGVHD, although

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e369f660eef66c9a4071121dbecc42
https://hal.sorbonne-universite.fr/hal-02552361

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání